Abstract
Thyroid adenomas belong to the cytogenetically best investigated human epithelial tumors. Cytogenetic studies of about 450 benign lesions allow one to distinguish between different cytogenetic subgroups. Two chromosomal regions, that is, 19q13 and 2p21, are frequently rearranged in these tumors. Although 2p21 aberrations only account for about 10% of the benign thyroid tumors with clonal cytogenetic deviations, 2p21 rearrangements belong to the most common cytogenetic rearrangements in epithelial tumors due to the high frequency of these benign lesions. The 2p21 breakpoint region recently has been delineated to a region of 450 kbp, but the gene affected by the cytogenetic rearrangements still has escaped detection. Positional cloning and 3′ RACE–PCR allowed us to clone that gene which we will refer to as thyroid adenoma associated (THADA) gene. In cells from two thyroid adenomas characterized by translocations t(2;20;3) (p21;q11.2;p25) and t(2;7)(p21;p15), respectively, we performed 3′-RACE–PCRs and found two fusions of THADA with a sequence derived from chromosome band 3p25 or with a sequence derived from chromosome band 7p15. The THADA gene spans roughly 365 kbp and, based on preliminary results, encodes a death receptor-interacting protein.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W and Lipman DJ . (1997). Nucleic Acids Res., 25, 3389–3402.
Bartnitzke S, Herrmann ME, Lobeck H, Zuschneid W, Neuhaus P and Bullerdiek J . (1989). Cancer Genet. Cytogenet., 39, 65–68.
Belge G, Kazmierczak B, Meyer-Bolte K, Bartnitzke S and Bullerdiek J . (1992). Cell. Biol. Int. Rep., 16, 339–347.
Belge G, Rippe V, Meiboom M, Drieschner N, Garcia E and Bullerdiek J . (2001). Cytogenet. Cell Genet., 93, 48–51.
Belge G, Roque L, Soares J, Bruckmann S, Thode B, Fonseca E, Clode A, Bartnitzke S, Castedo S and Bullerdiek J . (1998). Cancer Genet. Cytogenet., 101, 42–48.
Berner JM, Meza-Zepeda LA, Kools PF, Forus A, Schoenmakers EF, Van de Ven WJ, Fodstad O and Myklebost O . (1997). Oncogene, 14, 2935–2941.
Bol S, Belge G, Rippe V and Bullerdiek J . (2001). Cytogenet. Cell Genet., 95, 189–191.
Bol S, Belge G, Thode B, Bartnitzke S and Bullerdiek J . (1999). Cancer Genet. Cytogenet., 114, 75–77.
Bondeson L, Bengtsson A, Bondeson AG, Dahlenfors R, Grimelius L, Wedell B and Mark J . (1989). Cancer, 64, 680–685.
Bullerdiek J, Böschen C and Bartnitzke S . (1987). Cancer Genet. Cytogenet., 24, 205–212.
Dal Cin P, Sneyers W, Aly MS, Segers A, Ostijn F, Van Damme B and Van den Berghe H . (1992). Cancer Genet. Cytogenet., 60, 99–101.
Fedele M, Berlingieri MT, Scala S, Chiariotti L, Viglietto G, Rippel V, Bullerdiek J, Santoro M and Fusco A . (1998). Oncogene, 17, 413–418.
Feinberg AP and Vogelstein B . (1983). Anal. Biochem., 132, 6–13.
Kievits T, Dauwerse JG, Wiegant J, Devilee P, Breuning MH, Cornelisse CJ, Van Ommen GJ and Pearson PL . (1990). Cytogenet. Cell Genet., 53, 134–136.
Rippe V, Belge G, Meiboom M, Kazmierczak B, Fusco A and Bullerdiek J . (1999). Genes Chromosomes Cancer, 26, 229–236.
Teyssier JR, Liautaud-Roger F, Ferre D, Patey M and Dufer J . (1990). Cancer Genet. Cytogenet., 50, 249–263.
Acknowledgements
We thank Jessica Hommes for technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rippe, V., Drieschner, N., Meiboom, M. et al. Identification of a gene rearranged by 2p21 aberrations in thyroid adenomas. Oncogene 22, 6111–6114 (2003). https://doi.org/10.1038/sj.onc.1206867
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206867
Keywords
This article is cited by
-
THADA inhibition in mice protects against type 2 diabetes mellitus by improving pancreatic β-cell function and preserving β-cell mass
Nature Communications (2023)
-
A Comprehensive Overview of Common Polymorphic Variants in Genes Related to Polycystic Ovary Syndrome
Reproductive Sciences (2021)
-
Blood-based analysis of type-2 diabetes mellitus susceptibility genes identifies specific transcript variants with deregulated expression and association with disease risk
Scientific Reports (2019)
-
Molecular characterization of tumors meeting diagnostic criteria for the non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)
Virchows Archiv (2019)
-
Genome-wide association study identifies pharmacogenomic loci linked with specific antihypertensive drug treatment and new-onset diabetes
The Pharmacogenomics Journal (2018)